investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Novel Targeted Therapy for AML
Kapil Bhalla
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Leukaemia
James Y. Chen
Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating
Leukaemia
Neil Osheroff
Function and Biology of Eukaryotic DNA Topoisomerases
Leukaemia
Alan Rein
Retrovirus Assembly and Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
Kimberly Stegmaier
Validating Syk as a Target for AML Therapy
Leukaemia
Peng Huang
Novel Strategies to Target Leukemia-Stromal Interactions
Leukaemia
Michael R Green
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Michael L Cleary
Role of PGDH in leukemia pathogenesis
Leukaemia
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
